substance p has been researched along with Acute Lymphoid Leukemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, A; Barone, G; Chiaretti, A; Genovese, O; Lazzareschi, I; Maurizi, P; Paiano, S; Riccardi, R; Ruggiero, A; Sammartino, M | 1 |
| Coveñas, R; González-Ortega, A; Muñoz, M | 1 |
| Miśkowiak, B; Nowicki, M; Ostalska-Nowicka, D | 2 |
| Miśkowiak, B; Nowicki, M | 1 |
| Konwerska, A; Miskowiak, B; Nowicki, M; Ostalska-Nowicka, D | 1 |
| Rameshwar, P | 1 |
| Goso, C; Manzini, S; Potier, E; Szallasi, A | 1 |
8 other study(ies) available for substance p and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Propofol/alfentanil and propofol/ketamine procedural sedation in children with acute lymphoblastic leukaemia: safety, efficacy and their correlation with pain neuromediator expression.
Topics: Adolescent; Alfentanil; Anxiety; Child; Child, Preschool; Conscious Sedation; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Ketamine; Male; Nerve Growth Factor; Pain; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Propofol; Prospective Studies; Spinal Puncture; Substance P; Treatment Outcome | 2010 |
The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines.
Topics: Antineoplastic Agents; Apoptosis; Aprepitant; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Dose-Response Relationship, Drug; Female; Humans; Inhibitory Concentration 50; Morpholines; Neurokinin-1 Receptor Antagonists; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Real-Time Polymerase Chain Reaction; Receptors, Neurokinin-1; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Substance P; Tryptophan | 2012 |
Detection of substance P and its mRNA in human blast cells in childhood lymphoblastic leukaemia using immunocytochemistry and in situ hybridisation.
Topics: Adolescent; B-Lymphocytes; Biopsy, Needle; Bone Marrow; Cell Transformation, Neoplastic; Child; Child, Preschool; Humans; Immunohistochemistry; Immunophenotyping; In Situ Hybridization; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; RNA, Messenger; Substance P; T-Lymphocytes | 2003 |
Substance P--a potent risk factor in childhood lymphoblastic leukaemia.
Topics: Adolescent; Antigens, CD; B-Lymphocytes; Biotinylation; Bone Marrow Cells; Child; Child, Preschool; Disease Progression; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Leukemic; Glucocorticoids; Humans; Immunoenzyme Techniques; In Situ Hybridization; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; RNA Probes; RNA, Messenger; Substance P; T-Lymphocytes; Treatment Failure | 2003 |
The predicting role of substance P in the neoplastic transformation of the hypoplastic bone marrow.
Topics: Adolescent; B-Lymphocytes; Bone Marrow Diseases; Bone Marrow Examination; Cell Transformation, Neoplastic; Child; Child, Preschool; Disease Progression; Humans; Immunoenzyme Techniques; Immunophenotyping; In Situ Hybridization; Ki-67 Antigen; Leukemia; Leukemia, Myeloid, Acute; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Substance P | 2006 |
In vitro substance P-dependent induction of bone marrow cells in common (CD10) acute lymphoblastic leukaemia.
Topics: Adolescent; Bone Marrow Cells; Cell Proliferation; Child; Child, Preschool; Female; Humans; Interleukin-1beta; Male; Neurokinin-1 Receptor Antagonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Substance P | 2008 |
Is substance P central to the biology of acute lymphoblastic leukemia?
Topics: Bone Marrow Cells; Humans; Interleukin-1beta; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Substance P | 2008 |
Comparison of tachykinin NK1 receptors in human IM9 and U373 MG cells, using antagonist (FK888, (+/-)-CP-96,345, and RP 67580) binding.
Topics: Astrocytoma; Biphenyl Compounds; Dipeptides; Humans; Indoles; Isoindoles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Neurokinin-1; Substance P; Tumor Cells, Cultured | 1994 |